The Siemens Naeotom Alpha is the first commercialized photon-counting CT scanner. It gained FDA clearance Sept. 30, 2021. The image shows the system undergoing phantom testing with the outer covers off, showing the motion of the X-ray source and detector ring. Image by Deutscher Zukunftpreis/Ansgar Pudenz.
Ampoule sealing in crystal growth in the photon-counting CT defector production for the Siemens Naeotom Alpha system.

The U.S. Food and Drug Administration (FDA) cleared the world's first photon-counting computed tomography (CT) scanner, the Siemens Naeotom Alpha, on Sept. 30. Both FDA and CT experts say this is the start of a revolution in new CT scanner technology, and is the biggest shift in technology for this workhorse radiology modality in years.

The FDA sent out a rare press release on the approval, noting its importance to medical imaging. 

November 3, 2021 — MIM Software Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for additional automatically segmented contours and local deployment for Contour ProtégéAI, its robust AI auto-contouring solution.

MIM Software has received FDA 510(k) clearance for additional head and neck, thorax, prostate, and abdomen contours. Quality improvements to existing contours have also been implemented. 

November 3, 2021 — Mirion Technologies, Inc., a global provider of detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the acquisition of CHP Dosimetry, a U.S.-based distributor of dosimetry services. The acquisition closed on Nov. 1, 2021.

November 3, 2021 — “Brilliant workflows. Made for you.” is the key theme for international medical imaging IT and cybersecurity company Sectra in booth #8115 at the Radiological Society of North America (RSNA) 2021 Annual Meeting. The company will showcase its complete enterprise imaging offering and latest innovations for enhancing workflows to help tackle the growing workloads in radiology.

November 3, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement today from Laura Dawson, MD, FASTRO, Chair of the ASTRO Board of Directors, in response to the 2022 Medicare Physician Fee Schedule (MPFS) and Hospital Outpatient Prospective Payment System (HOPPS) final rules announced by the Centers for Medicare a

November 2, 2021 — PaxeraHealth has announced that it will be unveiling the Ark - a patent pending technology - at RSNA 2021.

A 37-year-old woman developed a new, palpable left supraclavicular lymphadenopathy lump five days after her first dose of the Moderna COVID-19 vaccine in the left arm. On the day of vaccination, the patient was asymptomatic. This is an example of how the vaccine can mimic cancer and swollen lymph nodes. Read more about this case study. Image used with permission of RSNA.

November 2, 2021 — Here is a list of the Top 10 most popular pieces of content on ITNonline.com from the month of October 2021. This is based on the website's 182,178 pageviews for the month. 

1. COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis

2. PHOTO GALLERY: How COVID-19 Appears on Medical Imaging

November 2, 2021 — Philips announced new innovations that can help improve cancer care across the patient journey at the American Society for Radiation Oncology (ASTRO) annual meeting (Chicago, USA, 24-27 October). During the event, Philips will demonstrate its Multimodality RT Simulation Workspace, a precision medicine application that provides a vendor-agnostic single space for simulation, multimodality image fusion and contouring.

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast cancer, presented data in an oral scientific session presentation at the American Society for Radiation Oncology (ASTRO) 63rd Annual Meeting held Oct.24 – 27, 2021, at McCormick Place West in Chicago, IL.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now